{"id":11556,"date":"2021-06-11T12:34:37","date_gmt":"2021-06-11T16:34:37","guid":{"rendered":"https:\/\/www.med.unc.edu\/tarc\/?page_id=11556"},"modified":"2024-11-25T14:38:49","modified_gmt":"2024-11-25T19:38:49","slug":"dr-ishizawars-research","status":"publish","type":"page","link":"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/","title":{"rendered":"Dr. Ishizawar&#8217;s Research"},"content":{"rendered":"<figure id=\"attachment_15766\" class=\"thumbnail wp-caption alignright\" style=\"width: 268px\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-15766\" src=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383-1024x1021.jpg\" alt=\"\" width=\"258\" height=\"257\" srcset=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383-1024x1021.jpg 1024w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383-300x300.jpg 300w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383-150x150.jpg 150w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383-768x766.jpg 768w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383-1536x1532.jpg 1536w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383-600x598.jpg 600w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383.jpg 1920w\" sizes=\"auto, (max-width: 258px) 100vw, 258px\" \/><figcaption class=\"caption wp-caption-text\">Dr. Rumey Ishizawar (middle) leads the Immuno-Oncology Group<\/figcaption><\/figure>\n<p>Dr. Rumey Ishizawar has a clinical and research interest in managing patients who <strong>develop autoimmune presentations \u2013 such as inflammatory arthritis \u2013 from cancer immunotherapy<\/strong>. This interest led her to develop the <strong>UNC Immuno-Oncology Group (IOG)<\/strong>.<\/p>\n<p>The IOG is a collaborative multidisciplinary group composed of clinicians as well as clinical and basic researchers at UNC from the fields of rheumatology, oncology, cardiology, dermatology, endocrinology, gastroenterology, oral medicine, nephrology, pharmacology and pulmonary medicine.<\/p>\n<p><strong>The IOG has two main objectives:<\/strong><br \/>\n<strong>1) Facilitate the clinical care of cancer patients<\/strong> who develop immune related adverse events (irAEs) from cancer immunotherapy, specifically immune checkpoint inhibitors (ICIs).<\/p>\n<p><strong>2) Advance clinical, translational and basic research defining the mechanisms leading to irAEs,<\/strong>\u00a0as these presentations can lead to better understanding of diverse autoimmune conditions.<\/p>\n<p>Since 2017, the IOG has engaged with over 30 clinicians and researchers across medical specialties in order to optimize care for cancer patients who develop irAEs. In these efforts, the clinicians together have developed clinical algorithms to facilitate patient referrals and management of irAEs. In addition, the IOG has built a research infrastructure to investigate irAEs.<\/p>\n<p><strong>This IOG research infrastructure has two arms:<\/strong><br \/>\n<strong>1) Retrospective study analysis of ICI use and\u00a0irAE\u00a0development <\/strong>through the UNC Healthcare System.<\/p>\n<p><strong>2) Prospective study enrolling patients starting ICI therapy and observing longitudinally for\u00a0irAE\u00a0development<\/strong>, which is described in more detail below.<\/p>\n<p>The IOG is grateful for the support from Thurston Arthritis Research Center and Lineberger Cancer Comprehensive Center.<\/p>\n<p><strong><em>The\u00a0Immune-Oncology Retrospective Study: Immune Checkpoint Inhibitor Use at UNC<\/em>,<\/strong> is a longstanding project examining treatments and outcomes of patients receiving ICI therapy at UNC since 2004. This project has supported residents and fellows across various medicine disciplines (Rheumatology, Pulmonary, Endocrine, Radiology, Hepatology), leading to several abstracts at national conferences, 2 publications, one accepted manuscript and others that are in preparation at this time.<\/p>\n<p><strong>The\u00a0Immuno-Oncology Prospective Database and\u00a0Bioregistry<\/strong> is a well-characterized longitudinal cohort of patients with standardized clinical data and biological samples for biomarker analysis, immunophenotyping, microbiome research, and genetic analysis to facilitate basic, clinical, and translational research. This study has been open to patient recruitment since February 2021.<\/p>\n<p><strong>Key Study Team Members:\u00a0<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-10816 \" src=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2021\/02\/Rumey-Ishizawar-mv2-150x150.jpg\" alt=\"\" width=\"132\" height=\"132\" srcset=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2021\/02\/Rumey-Ishizawar-mv2-150x150.jpg 150w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2021\/02\/Rumey-Ishizawar-mv2-600x600.jpg 600w\" sizes=\"auto, (max-width: 132px) 100vw, 132px\" \/><\/p>\n<p><a href=\"https:\/\/www.med.unc.edu\/tarc\/directory\/rumey-c-ishizawar-md-phd\/\"><strong>Rumey\u00a0C.\u00a0Ishizawar, MD, PhD<\/strong><\/a><br \/>\nAssistant Professor of Medicine<br \/>\nPrincipal Investigator<br \/>\n<a href=\"mailto:rumey_ishizawar@med.unc.edu\">rumey_ishizawar@med.unc.edu<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-11617\" src=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2021\/06\/Shruti-Saxena-Beem-2-sm-150x150.jpg\" alt=\"\" width=\"131\" height=\"131\" srcset=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2021\/06\/Shruti-Saxena-Beem-2-sm-150x150.jpg 150w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2021\/06\/Shruti-Saxena-Beem-2-sm-600x600.jpg 600w\" sizes=\"auto, (max-width: 131px) 100vw, 131px\" \/>Shruti Saxena-Beem<\/strong><br \/>\nClinical Research Coordinator<br \/>\n<a href=\"mailto:shruti_saxena@med.unc.edu\">shruti_saxena@med.unc.edu<\/a><br \/>\nPhone: (919) 966-0545<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-11631 \" src=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2021\/06\/IOG-2-Screenshot-2021-06-14-133846-rtp2-300x38.png\" alt=\"\" width=\"592\" height=\"75\" srcset=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2021\/06\/IOG-2-Screenshot-2021-06-14-133846-rtp2-300x38.png 300w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2021\/06\/IOG-2-Screenshot-2021-06-14-133846-rtp2-768x97.png 768w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2021\/06\/IOG-2-Screenshot-2021-06-14-133846-rtp2-600x76.png 600w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2021\/06\/IOG-2-Screenshot-2021-06-14-133846-rtp2.png 835w\" sizes=\"auto, (max-width: 592px) 100vw, 592px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Rumey Ishizawar has a clinical and research interest in managing patients who develop autoimmune presentations \u2013 such as inflammatory arthritis \u2013 from cancer immunotherapy. This interest led her to develop the UNC Immuno-Oncology Group (IOG). The IOG is a collaborative multidisciplinary group composed of clinicians as well as clinical and basic researchers at UNC &hellip; <a href=\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/\" aria-label=\"Read more about Dr. Ishizawar&#8217;s Research\">Read more<\/a><\/p>\n","protected":false},"author":58060,"featured_media":0,"parent":11538,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-11556","page","type-page","status-publish","hentry","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dr. Ishizawar&#039;s Research | Thurston Arthritis Research Center<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Ishizawar&#039;s Research | Thurston Arthritis Research Center\" \/>\n<meta property=\"og:description\" content=\"Dr. Rumey Ishizawar has a clinical and research interest in managing patients who develop autoimmune presentations \u2013 such as inflammatory arthritis \u2013 from cancer immunotherapy. This interest led her to develop the UNC Immuno-Oncology Group (IOG). The IOG is a collaborative multidisciplinary group composed of clinicians as well as clinical and basic researchers at UNC &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Thurston Arthritis Research Center\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/unctarc\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-25T19:38:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1915\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@UNCTARC\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/\",\"url\":\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/\",\"name\":\"Dr. Ishizawar's Research | Thurston Arthritis Research Center\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383-1024x1021.jpg\",\"datePublished\":\"2021-06-11T16:34:37+00:00\",\"dateModified\":\"2024-11-25T19:38:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383.jpg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383.jpg\",\"width\":1920,\"height\":1915,\"caption\":\"Dr. Rumey Ishizawar (middle) leads the Immuno Oncology Group\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/tarc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Additional information about our researchers&#8217; areas of focus\",\"item\":\"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Dr. Ishizawar&#8217;s Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/tarc\/\",\"name\":\"Thurston Arthritis Research Center\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/tarc\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Ishizawar's Research | Thurston Arthritis Research Center","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Ishizawar's Research | Thurston Arthritis Research Center","og_description":"Dr. Rumey Ishizawar has a clinical and research interest in managing patients who develop autoimmune presentations \u2013 such as inflammatory arthritis \u2013 from cancer immunotherapy. This interest led her to develop the UNC Immuno-Oncology Group (IOG). The IOG is a collaborative multidisciplinary group composed of clinicians as well as clinical and basic researchers at UNC &hellip; Read more","og_url":"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/","og_site_name":"Thurston Arthritis Research Center","article_publisher":"https:\/\/www.facebook.com\/unctarc","article_modified_time":"2024-11-25T19:38:49+00:00","og_image":[{"width":1920,"height":1915,"url":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@UNCTARC","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/","url":"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/","name":"Dr. Ishizawar's Research | Thurston Arthritis Research Center","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/tarc\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383-1024x1021.jpg","datePublished":"2021-06-11T16:34:37+00:00","dateModified":"2024-11-25T19:38:49+00:00","breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/#primaryimage","url":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383.jpg","contentUrl":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2024\/02\/MicrosoftTeams-image-1-scaled-e1707336128383.jpg","width":1920,"height":1915,"caption":"Dr. Rumey Ishizawar (middle) leads the Immuno Oncology Group"},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/dr-ishizawars-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/tarc\/"},{"@type":"ListItem","position":2,"name":"Additional information about our researchers&#8217; areas of focus","item":"https:\/\/www.med.unc.edu\/tarc\/more-information-about-our-research\/"},{"@type":"ListItem","position":3,"name":"Dr. Ishizawar&#8217;s Research"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/tarc\/#website","url":"https:\/\/www.med.unc.edu\/tarc\/","name":"Thurston Arthritis Research Center","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/tarc\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/pages\/11556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/users\/58060"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/comments?post=11556"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/pages\/11556\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/pages\/11538"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/media?parent=11556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}